chrisvoncsefalvay/vaers-outcomes huggingface dataset:
HPV #1 administered on 3/3/08 along w/ Td vaccine. Pt diagnosed with intermediate uveitis both eyes 4/30/08.  10/10/07 Reviewed opthamology records of 4/30-5/28/08. FINAL DX: amblyopia, peripheral fibrovitreous with empty vitrous left eye, peripheral uveitis, granuloma Records reveal patient experienced vitreous fibrosis, longstanding floaters of both eyes, seeing 'ghosting around images' x 1 year.  10/3/08 Reviewed PCP medical records of 3/3/08. FINAL DX: none provided Record reveals patient experienced usual state of good health on day of vaccination.  BMI 90% although very active.  No record provided for Td, only HPV. No other records available at this time.  10/17/08 Reviewed additional medical records of 5/1-9/17/2008. FINAL DX: bilateral peripheral uveitis, vitreoretinal disease, bilateral pars planitis, possible familial exudative vitreoretinopathy, keratosis pilaris, mottling of skin over legs.
Tinnitus - primarily in right ear, slightly in left ear but very much louder in right.
2/3/21 Started with headache. Then overnight fever and chills. Dizzy, body ache, frequent urination. Next morning 2/4/21, fever, headache, upset stomach, body aches, fatigue. I had to quit work and go to bed.  2/5/21 fever has passed. Still have headache and some body aches.
During administration of the vaccine the needle detached from the syringe resulting in a small amount of vaccine spraying onto the patients arm
Fever, body aches, chills, pain, swelling toright arm with cellulitis.
PT reports intermittent epigastric pain described as sharp x 04/09 after receiving JJ vaccine. reports nausea, denies vomiting and diarrhea.Patient is a 63 year old female who presents to ED with epigastric pain for 5 days, sharps, rated 9/10 associated with nausea. She denies any fever, no vomiting. She states the pain started one day after receiving the J&J vaccine.  She has had some headache, denies any chest pain or shortness of breath. She was recently diagnosed with elevated cholesterol, has not had treatment for it yet. She had a colonoscopy with benign polyp removed, no other abdominal procedures.
increasing redness & urticaria on rt upper arm p/vax was given x 4 days ago;
Redness, induration 1st day, warmth 2nd day, which started after injection which increased daily until area was 10cm. Fever & headache.
Patient was admitted due to progressive lower extremity weakness.  He also reported developing numbness in his fingers.  He was diagnosed with Guillian-Barre syndrome secondary to influenza vaccine.  He received an influenza vaccine on 11/8/19 (Sanofi Pasteur Lot:  UJ285AB).  Neurology was consulted.  They did not recommend any specific treatment, but rather supportive care.  He was discharged with instructions to follow up with neurology if his symptoms did not resolve within a month.
Initial unsolicited report received from a nurse on 16 October 2015. This case involves a 14-years-old male patient who was vaccinated with a dose of FLUZONE QIV (batch number: UI462AB, expiry date: 30 June 2016, dose, dose in series were not reported) via intramuscular route in left deltoid on 14 October 2015. The patient's illness at time of vaccination reported was not reported, pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) reported as none known. Any other vaccinations within 4 weeks of vaccinations were not reported. Concomitant medications were not reported. On 15 October 2015, one day following the vaccination, the patient woke up with swelling at left axilla area and severe pain of left arm and it hurts to move arm up and down. The patient had received vaccine several times previously. Laboratory data and corrective treatment were not reported. The patient was not recovered from the events. List of documents held by sender: none.
Information has been received from a registered nurse (R.N.), referring to a patient of unknown age and gender. No relevant medical history or concurrent conditions were reported. On 13-SEP-2016, the patient was vaccinated with ROTATEQ (lot # L046320, expiration date 29-SEP-2017, oral; dose and dose number were not reported) and PEDVAXHIB (M014925, expiration date 16-FEB-2019, intramuscular; dose and dose number were not reported), both of which had been exposed to a temperature excursion (25.0 Fahrenheit for 1 hour) on 12-SEP-2016. No known adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
pain at injection site/Injection site burning/soreness at injection site; itching at injection site; rash at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th December 2019, the patient received the 1st dose of Shingrix (intramuscular). In December 2019, less than a week after receiving Shingrix, the patient experienced injection site pain, injection site itching and injection site rash. On an unknown date, the outcome of the injection site pain, injection site itching and injection site rash were unknown.   It was unknown if the reporter considered the injection site pain, injection site itching and injection site rash to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix and has experienced pain, rash, soreness, burning and itching at the injection site. The reporter did not consent to follow up.
Nausea; aches; joint pain; chills; This is a spontaneous report from a contactable consumer (patient herself). a 25-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL3247, expiry date: unknown) via unspecified route of administration in left arm, on17Feb2021 (age at vaccination: 25-years) as dose 2, single for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Historical vaccine included first dose (lot number: EL3247) via unspecified route of administration, in left arm on 27Jan2021 01:00 PM, as dose 1, single for Covid-19 immunisation. Past drug event included known allergies of amoxicillin. Patients medical history and concomitant medications were not reported. No other vaccine in four weeks was administered. In two weeks patient was administered birth control medications. On 18Feb2021, patient experienced nausea, aches, joint pain, chills. No treatment was given as a result of the adverse events. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of event was recovering.   Follow-up attempts completed. No further information expected.
Delivery date is April 3, 2021; First pregnancy; Arm was a little sore around the injection site and stung when injected. After a few hours I noticed a small red bump start forming within a few hours it was tender and warm. The next morning the bump had grown to the size of a golf ball and was swollen, tender and warm to the touch.  The following morning it was even more tender, a bulge about the size of a peach, extremely red and hot to the touch. I consulted with the team doctor and he ended up prescribing me an antibiotic because he believed it was an infection.
At approximately 6pm I experienced chest tightening and pain above my heart.  When taking deep breaths the pain became more sharp.  The pain lasted about 3 days, gradually decreasing each day.  At the time I attributed it to stress, as the day and recently I have experienced stress at work.  I did not seek medical attention as it improved over time, and has not returned.  I decided to report when hearing about the heart inflammation reports, and this was about 1.5 weeks after my 2nd dose.  Symptoms do overlap with stress (what I originally attributed to) and what I have read are symptoms of hear inflammation.  My adverse events that followed my 2nd vaccine (minor fever, aches, headaches, swollen lymph nodes, etc) only onset about 20 hours post vaccine, and lingered longer than most people that I know.
Pain in neck on side of second COVID-19 injection (left side). Debilitating pain when neck turned in certain direction. Pain also up through hair with swelling. Did not respond very well to typical neck ache methods-ice, heat, massage. Ten day duration though still can feel tenderness.
Localized swelling w/spread, pos exaggerated local rxn vs cellulitis;
Body aches and pains, joint paint from ankles to jaw, shakes from feeling extreme cold, fever - overnight rose to 102°
Headache, Myalgia, Arthralgia, Diarrhea, NauseaVomiting, Fatigue/ Chills
NECK PAIN; SHOULDER PAIN; FATIGUE; RED INJECTION SITE; HEADACHE; This spontaneous report received from a patient via a company representative concerned a 52 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: difficulties in intimacy, felt self conscious, itchy, skin affected social, leisure activities, skin had prevented from working, sore, painful, right shoulder pain, hidradenitis suppurativa, and skin pain, stinging skin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on 21-SEP-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On SEP-2021, the patient experienced neck pain. On SEP-2021, the patient experienced shoulder pain. On SEP-2021, the patient experienced fatigue. On SEP-2021, the patient experienced red injection site. On SEP-2021, the patient experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from neck pain, shoulder pain, fatigue, red injection site, and headache on SEP-2021. This report was non-serious.
Nausea at 10:00pm day of injection  Day 2: fever 100°, cough, muscle aches, chills, painful arm  Day 3: lingering cough, muscle aches, chills, painful arm   Day 4: fatigue, lingering muscle aches & arm pain  Day 5: fatigue, lingering muscle aches & arm pain
Diagnosed with 3 deep vein thrombosis blood clots in my left leg. Currently on blood thinners but still have mild occasional discomfort.
This spontaneous report as received from a consumer refers to her mother, a 98 years old patient with high blood pressure and allergy to hydrocodone. On 19-JUL-2012 the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX (lot# reported as 0255AE, exp. date 14-MAR-2013) for prevention of shingles. Concomitant medications included unspecified high blood pressure medication. In approximately July, 2012 (reported as soon after vaccination) the patient experienced redness and pain at the injection site. She noted that her mother could not touch or lie down because of the pain. She took her mother to an unspecified dermatologist yesterday on 07-AUG-2012 who stated that the reaction was a sterile abscess. The consumer stated that the area around her mother's injection site was still very red, dark, uncomfortable and 4 inches long and 3 inches wide. No treatment was given for the adverse events. No lab diagnostics studies performed. The outcome of the patient was reported as recovering. Additional information has been requested.
Patient says her arm has been raised swollen pink and sore every since her shot. She went to her doctor and he said to report the incident to VAERS.
This case was reported by a lawyer and described the occurrence of Bell's palsy in a female subject of unspecified age who was vaccinated with Lyme disease vaccine recombinant Lymerix for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Lymerix (unknown). At an unspecified time after vaccination with Lymerix, the subject experienced arthralgias, fatigue, Bells palsy, jaw pain, gastrointestinal problems, eye problems, headaches, myalgias, tinnitus, twitching, numbness and tingling, poor balance, night sweats, memory loss ,sinus problems, loss of concentration, rashes, dizziness, shortness of breath, back pain, and rheumatologic, neurologic and or cognitive impairment of an autoimmune, immune mediated, or other mechanism, all reportedly caused by vaccination with Lymerix. She also experienced decreased activities of daily life and decreased ability to participate in recreational activities. At the time of reporting the out come of the events was unspecified. This case was assessed as medically serious by manufacturer (OMIC). This information was received via a statement of injuries.
Fever, chills, felt like throwing up (but did not), very weak, upset stomach.
Light-headed, dizzy, slight puffiness near injection site, started to pass out but not totally. Vitals - ok; BP slightly low. Treated with Diphenhydramine 50mg p.o. Responded well, went home and slept for 1 1/2 hours. Follow up phone call on 10/24 at 2:05 PM - No adverse effects. She felt strong and well.
At approximately 30 minutes post vaccine, pt  felt short of breath, had throat closing sensations, and had hives, EMS was activated. En route to the ED, EMS gave the patient epinephrine 0.3 mg IM, benadryl 50 mg, and a breathing treatment.
sleepy, chest hurting-felt like hands were large hands itching, dizzy, could not walk -too weak;
Local reaction (L) thigh with 2 inch circular, red area, central blush component. No induration
My feet started tingling and then I lost my memory of the next months. Muscle weakness in both legs and unable to walk to end up paralyzed from the nose down.
Right after receiving the vaccine my thumb started to swell. I took a picture of it because I couldn't believe the size. For the next three mornings I woke up with a headache. I took Tylenol and it helped get rid of the headaches. I started to see unexplained bruising on my arms and legs a week after the vaccination. To this day, I still have bruising, but it is going away. I noticed that I was getting Petechiae (tiny red, flat spots that appear on the skin). I noticed a bruise on my breast ( I am a breast cancer survivor and have had reconstructive surgery on my breasts.) After the bruise started to disappear, my skin was already thin from radiation, but the skin started to open up and expose my silicone inside my breast. I had to go to the surgeon and my implant had to be removed. Now I am flat chested on that side. This is going to take several weeks of recovery to get through this. The surgery for the removal of the silicone was 9PM PST, Emergency Surgery.
weak; Tired; felt warm but does not know if they had a fever; itching at the injection; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), FATIGUE (Tired), FEELING HOT (felt warm but does not know if they had a fever) and VACCINATION SITE PRURITUS (itching at the injection) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No past medical history was reported.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ASTHENIA (weak), FATIGUE (Tired) and FEELING HOT (felt warm but does not know if they had a fever). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (itching at the injection). At the time of the report, ASTHENIA (weak), FATIGUE (Tired), FEELING HOT (felt warm but does not know if they had a fever) and VACCINATION SITE PRURITUS (itching at the injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No concomitant product was reported.
Had 4 Modena shots. This is first Pfizer.  1st 36h had usual side effect:headache and low fever. Not feeling great  Since day 2 have mild inconvenience in left hand but about 4 times in 24h when  using my left hand for a minor effort (like opening a baby gate) I had  excruciating pain radiate through my left hand. It goes away within 5 seconds from 9/10 to 2/10
Pain at injection site; General Arm pain; they are barely able to use the arm, due to the pain; HCP hit the bone while injecting  dose; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th January 2023, the patient received the 2nd dose of Shingrix. On 10th January 2023, unknown after receiving Shingrix, the patient experienced wrong technique in drug usage process. On 13th January 2023, the patient experienced injection site pain, pain in arm and injected limb mobility decreased. On an unknown date, the outcome of the injection site pain, pain in arm and injected limb mobility decreased were not recovered/not resolved and the outcome of the wrong technique in drug usage process was unknown.   It was unknown if the reporter considered the injection site pain, pain in arm and injected limb mobility decreased to be related to Shingrix.     Additional Information: GSK receipt date: 13 JAN 2023 Reporters comment:  The reporter reported that the patient received the 2nd dose of Shingrix on Tuesday 10th January 2023. The reporter stated that the patient experienced pain at the injection site, general arm pain and was barely able to use the arm on Friday 13th January 2023. The patient administered the dose advised they had hit the bone while injecting the dose. Additional  supportive information: As patient had hit the bone while injecting the dose which led to wrong technique in drug usage process. The reporter did not consent to follow up.
Headache, Myalgia, Arthralgia, malaise, chills Narrative:
swelling & pain in area where vax was given w/in 6-8hrs;APAP for pain, warm compresses for swelling;sxs disappeared w/in 1-2 days;
Pt verbalized that she felt like her throat was tight. Pt assessed from head to toe, Distress denied. Pt had taken Benadryl 25 and prednisone prior to making room attendant RN aware. Upon auscultation, no wheezing noted. Pt blood pressure was 158/100, HR 128, o2 sat was 98%. Pt verbalized that her baseline HR was around 118 and that she had anxiety. Pt was diaphoretic upon exam and asked for a bottle of water. Pt's request was honored. Pt walked around the room to relieve her anxiety and said she felt better.   Her HR went down to 90 after walking around the room. Pt was offered IM diphenhydramine and refused. Pt also refused Ambulance to transfer her to ER. At 4:30 pm patient took another Benadryl PO without medical advice. Pt is a registered nurse and wanted to be transferred to ER, where she works, by another RN.  Pt left facility against medical advice and declined EMS at 4:40 pm. BP was 190/140 and HR 104 when she left facility to go to ER, transported in private vehicle by coworker who is an RN. Called ER to check on pt and physician said she had recovered and that she did not require any further medical attention, the event was believed to have been anxiety related.
APPROXIMATLEY 10 MINS AFTER GETTING THE VACCINE, PT COMPLAINED THAT HER THROAT WAS NUMB AND FELT DIFFERENT. WE GAVIE HER 50MG OF DIPHENHYDRAMINE AND HAD HER SIT FOR ANOTHER 20MINS. WE FREQUENTLY CHECKED ON HER AND SHE SAID HER SYMPTOMS WERE A LITTLE BIT BETTER, NOT GETTING WORST. CONSULTED PT TO TAKE BENADRYL OTC Q 6 HOURS FOR THE REST OF THE DAY AND TO FOLLOW UP WITH PCP. SHE WAS ADVISE TO CALL 911 OR SEE EMERGENCY HELP IF SYMPTOMS WORSEN.  WE TRIED TO CALL SEVERAL HRS TO CHECK ON HER BUT SHE DID NOT PICK UP. THE NEXT DAY WE CALLED AGAIN AND PT STATED HER THROAT/SYMPTOMS WERE BETTER AND THAT SHE HAD FOLLOWED UP WITH PER PCP.
This spontaneous report was received from a registered nurse, refers to a 20 year old female patient. No pertinent medical history was reported. On 11-APR-2014, reported as today, the patient was vaccinated with MMR II, (lot # 0686AE; Exp. Date: 02-APR-2014), Dose: 0.5 ml, subcutaneous injection in the left arm. Co-suspect or concomitant therapies were not reported. The reporter nurse stated that patient was vaccinated with expired MMR II vaccine. No adverse effects reported.At the time of the report, the outcome of the event was unknown. Additional information is not expected.
swelling came back; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling came back) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053cz1a and 027c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SWELLING (swelling came back). At the time of the report, SWELLING (swelling came back) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable. No concomitants were reported. No treatment medication were reported.   This case was linked to MOD-2021-230063 (Patient Link).
dry lips; rash on arms and torso; swelling in limbs; overall itching; This case was reported by a pharmacist via call center representative and described the occurrence of lip dry in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number 7742z, expiry date 25th March 2023) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE for prophylaxis.   On 14th September 2021, the patient received Shingrix (intramuscular) and INFLUENZA VACCINE. In September 2021, 2 weeks after receiving Shingrix, the patient experienced lip dry, rash, swelling of limb and generalized pruritus. On an unknown date, the outcome of the lip dry, rash, swelling of limb and generalized pruritus were unknown.   It was unknown if the reporter considered the lip dry, rash, swelling of limb and generalized pruritus to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that the patient received the Shingrix and a non-GSK flu vaccine on the same day and experienced dry lips, rash on arms and torso, swelling in limbs, and overall itching. The patient did not have any symptoms until 2 weeks after his vaccines. The reporter spoke per content and referred patient to healthcare professional. The reporter did not consent to follow-up.
Information was received from a physician concerning a patient of unknown age and gender, who on an unknown date, was administered dose three of "GARDASIL 4" or GARDASIL 9 (dosages, routes of administration, lot numbers and expiration dates not provided) less than 12 weeks after the second dose. No further details were provided. Additional information has been requested.
This spontaneous report as received from a physician refers to a 12 month old patient of an unknown gender. On 29-JUL-2014, the patient was vaccinated with M-M-R II (HSA) dose 1 (lot number: 0684AE), exp date 02-APR-2014 (dose and route were not reported) that expired on 02-APR-2014. No concomitant medications were reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Joint pain, Muscle Spasms, muscular pain, abdominal and hip pain.
Severe abdominal cramping, nausea, vomiting, diarrhea, fatigue, and cold sweats. After being sent home and napping, I woke up to severe muscle and join pain all over my body. This continues today, 06/29/2010.
pt devel a maculopapular rash p/receiving flu vax; rash which was assoc w/pruritus began on the abdomen, spread to extremities, but did not involve the head;